Department of Medicine
-
January 24, 2022
Vanderbilt recruiting children to study allergic responses to COVID-19 mRNA vaccines
Vanderbilt is conducting a clinical trial to determine risk and mechanisms of allergic reactions to COVID-19 Pfizer-BioNTech mRNA vaccine among children. -
January 20, 2022
Erasmus named medical director of the Vanderbilt Lung Transplant Program
David Erasmus, MBChB, MD, assistant professor of Medicine, joined Vanderbilt University Medical Center earlier this month as medical director of the Vanderbilt Lung Transplant Program. -
January 20, 2022
Pozzi elected president of Society for Matrix Biology
Vanderbilt's Ambra Pozzi, PhD, has been elected president of the American Society for Matrix Biology (ASMB), a scientific organization that promotes research on the extracellular matrix with the aim of improving human health. -
January 18, 2022
Ensuring the “best possible” medication history
About 80% of hospital admission electronic records were missing a drug prescribed to an older adult, Vanderbilt researchers found, highlighting the need for a multipronged approach to address medication discrepancies and support safe prescribing practices. -
January 17, 2022
H. pylori, lipid loss and stomach cancer
H. pylori infection — a strong risk factor for stomach cancer — changes the composition of stomach lipids, which could offer new biomarkers for detecting premalignant changes, Vanderbilt researchers discovered. -
January 13, 2022
The role of integrins in kidney “integrity”
Receptors called integrins play a critical role in maintaining the structure of the kidney, Vanderbilt researchers have discovered. -
January 11, 2022
New Clinician Spotlight: Michael Lester
Michael Lester, MD, has joined Vanderbilt University Medical Center after completing seven years of internship, residency and fellowship here.